Liu, Y. How Do Varying Concentrations and Treatment Durations of Anti-PDL1 Antibodies Affect HCT116 Cell Viability, Xenograft Tumor Size, and T Cell Activation, As Measured by MTT Assay, Tumor Weight, and IL-2 Production, Respectively?. MS 2024, 2, 2912.